Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 3, 1996, Pages 780-783

  Stoeckel, Klaus ^a   Harell, Moshe ^b   Dan, Michael ^b  

^a Clinpharm Support   (Switzerland)

^b WOLFSON MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CEFETAMET; CEFETAMET PIVOXIL; CEFUROXIME; CEFUROXIME AXETIL;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PENETRATION; DRUG TISSUE LEVEL; FEMALE; HUMAN; MALE; MAXILLA SINUSITIS; MAXILLARY SINUS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030028748     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.3.780     Document Type: Article

References (21)

1. Blouin, R. A., and K. Stoeckel. 1993. Cefetamet pivoxil clinical pharmacokinetics. Clin. Pharmacokinet. 25:172-188.
2. Bryan, J. 1991 Cephalosporins and carbapenems. Curr Opin. Infect. Dis. 4:727-741.
3. Craig, W. A., and B. Vogelman. 1984. Changing concepts and new applications of antibiotic pharmacokinetics Am. J. Med. 77(Suppl. 1B):24-28
4. Dellamonica, P. 1994. Cefuroxime axetil. Int. J. Antimicrob. Agents 4:23-36.
5. Drusano, G. L. 1988. Role of pharmacokinetics in the outcome of infections. Antimicrob. Agents Chemother. 32:289-297.
6. Ducharme, M. P., D. J. Edwards, P. J. McNamara, and K. Stoeckel. 1993. Bioavailability of syrup and tablet formulations of cefetamet pivoxil. Antimicrob. Agents Chemother. 37:2706-2709.
7. Fass, R. J., and V. L. Helsel. 1986. In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins. Antimicrob. Agents Chemother. 30:429-434
8. Finn, A., A. Straughn, M. Meyer, and J. Chubb. 1987. Effect of dose and food on the bioavailability of cefuroxime axetil. Biopharm. Drug Dispos. 8:519-526.
9. Gauger, U., P. Inoka, G. Germano, and M. Kissling. 1990 Cefetamet in the treatment of acute sinusitis in adult patients. J. Int. Med Res. 18:228-234
10. Gehanno, P., I. Boncot, D. Chiche, and P. Berche. 1991. Out-patient treatment of acute sinusitis: comparative evaluation of cefuroxime axetil and cefixime. Med. Mal. Infect. 21:61-65 (Out of series.)
11. Gold, B., and W. J. Rodriguez. 1983 Cefuroxime: mechanisms of action, antimicrobial activity, pharmacokinetics, clinical applications, adverse reactions, and therapeutic indications. Pharmacotherapy 3:82-100.
12. Jousimies-Somer, H. R., S. Savolainen, and J. S. Ylikoski. 1988. Bacteriological findings of acute maxillary sinusitis in young adults. J. Clin. Microbiol. 26:1919-1925.
13. Nix, D. E., S. D. Goodwill, C. A. Peloquin, D. L. Rotella, and J. J. Schentag. 1991. Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning. Antimicrob. Agents Chemother. 35:1947-1952.
14. Quintiliani, R., C. H. Nightingale, and C. D. Freeman. 1994. Pharmacokinetic and pharmacodynamic consideration in antibiotic selection, with particular attention to oral cephalosporins. Infect. Dis. Clin. Pract. 3:1-7.
15. Schentag, J. J. 1989. Clinical significance of antibiotic tissue penetration. Clin. Pharmacokinet. 16(Suppl. 1):25-31.
16. Schentag, J. J., I. L. Smith, D. J. Swanson, C. DeAngeli, J. E. Fracasso, A. Van, and J. W. Vance. 1984. Role for dual individualization with cefmenoxime. Am. J. Med 77(Suppl. 6A):43-50
17. Stoeckel, K., W. L. Hayton, and D. J. Edwards. 1995. Clinical pharmacokinetics of oral cephalosporins Antibiot Chemother. (Basel) 47:34-71
18. Vogelman, B., and W. A. Craig. 1986. Kinetics of antimicrobial activity J. Pediatr. 108:835-840.
19. Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnidge, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis 158:831-847.
20. Wald, E. R. 1988. Sinusitis in children. Pediatr. Infect Dis. J. 7:150-153.
21. Wyss, R., and F. Bucheli. 1988. Determination of cefetamet and its orally active ester, cefetamet pivoxil, in biological fluids by high-performance liquid chromatography. J. Chromatogr. Biomed. Appl. 430:81-92.